What Happened?
Vancouver, BC-based Aquinox Pharmaceuticals Resigned Shelley McCloskey as Vice President of Human Resources and Administration
About the Company
Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology. Aquinox`s lead drug candidate, AQX-1125, is a small molecule activator of SHIP1 suitable for oral, once daily dosing. Aquinox has a broad intellectual property portfolio and pipeline of preclinical drug candidates that activate SHIP1.
About the Person
Shelley McCloskey is Senior Vice President of Human Resources at Xenon Pharmateuticals. Previously, Shelley held various senior HR leadership roles in the industry.
Info Source
News
Short Profile